News

AddToAny

Google+ Facebook Twitter Twitter

Observing blood infections

For the first time ever, researchers have been able to observe live, in real-time, how the human body responds to often lethal fungal blood infections in the lungs.

Observing blood infections

In the study, the fungal infection Candida albicans was introduced to mice or human models of the lung vasculature.

As blood was pumped over that system, researchers recorded what happened using highly sophisticated microscopes.

Immune cells rushed to the scene of the infection, which was expected. But then those cells swarmed, clustered and jammed up the blood vessels causing a potentially dangerous blockage.

The researchers, from the University of Calgary’s Cumming School of Medicine, said this was a revelation that could lead to new treatment options for the usually deadly incursions.

This clumping of immune cells was captured in high resolution for the research, which has been published in the journal Cell Host and Microbe.

bit.ly/BS_MayNews02

Related Articles

Blood Bag

Change for blood transfusion inspections

Chris Elliott, Chair of the IBMS Specialist Advisory Panel (Transfusion), discusses changes in the MHRA assessment and inspection regime for hospital blood transfusion laboratories. 

Journal-based learning: iStock

May: Journal-based learning

Each article’s contents should be read, researched and understood, and you should then come to a decision on each question. The pass mark is 17 out of 20 questions answered correctly. JBL exercises may be completed at any time until the published deadline date. Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl

CRP analyser aids early decision making

New research indicates HORIBA Medical UK’s Microsemi point-of-care (POC) CRP analyser enables rapid clinical decision-making, saves time and reduces costs in emergency paediatric units.

Introduce mutations to tackle sickle cell

Introduce mutations to tackle sickle cell

Researchers in Australia have found a way to introduce natural mutations into blood cells that could lead to new therapies for sickle cell anaemia and other blood disorders.

Top